The ISSCR Comments on Public and Stakeholder Consultations for the Revision of the EU BTC Legislation

European Commission.
Comments focus on concerns regarding the premature commercialization of cellular therapies and the implications of the BTC legislation for the oversight of Advanced Therapy Medicinal Products (ATMPs).
Read the comments.